We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is Endocervical Adenocarcinoma?

By H. Colledge
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Endocervical adenocarcinoma is a type of cancer which affects the cervix. The cervix is the lowest end of the uterus, sometimes known as the neck of the uterus. Adenocarcinoma, which develops from glandular tissue, is not as common as the most frequently occurring cervical cancer, squamous cell carcinoma, which arises from the epithelium covering the cervix. As endocervical adenocarcinoma arises in cells located inside the endocervical canal, the passage inside the cervix, the cancer is much harder to detect than squamous cell carcinoma, which develops on the surface of the cervix. Treatment may involve surgery, radiotherapy and chemotherapy, but the specific therapy used, and the outlook after treatment, will vary depending on how far the cancer has advanced.

Adenomatous cells, from which endocervical adenocarcinoma develops, are located in the lining of the endocervical canal, where they produce mucus. While endocervical adenocarcinoma is less frequently seen than squamous cell carcinoma, it is becoming more common. Although the two main cancer types which affect the cervix develop from different cells, both kinds of cancerous growths may give rise to similar symptoms and may be treated using the same methods.

The symptoms of squamous cell carcinoma or endocervical adenocarcinoma may not be obvious, especially at first, but abnormal bleeding from the vagina is sometimes seen. This could be bleeding that occurs in a woman who has already gone through menopause, which arises after sexual intercourse, or which occurs in between periods. Occasionally, an unpleasant-smelling vaginal discharge is experienced, or there may be discomfort during sex. Sometimes a woman with endocervical adenocarcinoma does not notice any symptoms, but a cervical screening test detects signs of cancer, although screening is less effective than in the case of squamous cell carcinoma.

When endocervical adenocarcinoma is suspected, samples of cells from the endocervix may be taken and a cone biopsy may be carried out, where a small section of the cervix is removed for analysis under a microscope. Cancer staging is performed to determine the extent to which the cancer has progressed. The stage of the cancer then dictates the treatment plan. In the early stages, endocervical adenocarcinoma may be cured, and treatment generally consists of surgery, radiotherapy, or a combination of the two. Advanced cancers, which have spread beyond the cervix and the top of the vagina, can sometimes be cured using surgery, radiotherapy and chemotherapy, as long as they have not spread to distant parts of the body.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.